Enfortumab Vedotin Plus Pembrolizumab (EV+P) Vs Chemotherapy (Chemo) in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC): Pan-Asian Subgroup Analysis From EV-302/KEYNOTE-A39